Current Pharmaceutical Design

Author(s): Michael Bukrinsky, Alexander Orekhov, Michael Ditiatkovski and Dmitri Sviridov

DOI: 10.2174/1381612811319330009

Cyclophilins in Atherosclerosis: A New Therapeutic Target?

Page: [5904 - 5908] Pages: 5

  • * (Excluding Mailing and Handling)

Abstract

Atherosclerosis is a chronic disease with a significant inflammatory component. Recent studies indicate a role of extracellular cyclophilins as contributors to endothelial inflammation and pathogenesis of atherosclerosis. In this article, we review current literature on pro-inflammatory activities of extracellular cyclophilins and discuss possible approaches to selectively target this novel proinflammatory factor.

Keywords: Extracellular cyclophilins, chemotaxis, inflammation, CD147, leukocytes, monocytes.